Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $98.44
- Average 1Y price target
- $134.33+36.46%
- Agreement
- Good
Analysts agreement range is spread less than 15% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall4
- DCF4
- Return on equity4
- Return on assets4
- Debt / equity1
- P/E3
- P/B4
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 11 | $134.82 |
| All time | 31 | $109.16 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Oct 28, 2026 | BNP Paribas | maintain | Outperform | Outperform |
| Oct 27, 2026 | Needham | maintain | Buy | Buy |
| Jul 29, 2026 | Needham | maintain | Buy | Buy |
| May 20, 2026 | Stephens & Co. | maintain | Overweight | Overweight |
| Apr 29, 2026 | TD Cowen | maintain | Buy | Buy |
| Apr 16, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 16, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Feb 18, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 18, 2026 | Baird | upgrade | Neutral | Outperform |
| Feb 17, 2026 | Guggenheim | downgrade | Buy | Neutral |
| Feb 13, 2026 | Guggenheim | downgrade | Buy | Neutral |
| Jan 27, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jan 5, 2026 | Johnson Rice | maintain | Accumulate | Buy |
| Nov 4, 2025 | Argus Research | downgrade | Buy | Hold |
| Oct 31, 2025 | Baird | downgrade | Outperform | Neutral |
| Oct 16, 2025 | JP Morgan | maintain | Overweight | Overweight |
| Oct 7, 2025 | Stephens & Co. | maintain | Equal Weight | Equal Weight |
| Jul 31, 2025 | JP Morgan | upgrade | Neutral | Overweight |
| Jul 22, 2025 | Roth Capital | maintain | Buy | Buy |
| Jul 22, 2025 | JP Morgan | maintain | Neutral | Neutral |
| Jul 14, 2025 | Guggenheim | maintain | Buy | Buy |
| May 5, 2025 | Piper Sandler | maintain | Neutral | Neutral |
| Apr 17, 2025 | Guggenheim | maintain | Buy | Buy |
| Feb 27, 2025 | Piper Sandler | maintain | Neutral | Neutral |
| Feb 27, 2025 | Guggenheim | maintain | Buy | Buy |
| Feb 26, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 26, 2025 | Canaccord Genuity | maintain | Buy | Buy |
| Nov 6, 2024 | Guggenheim | maintain | Buy | Buy |
| Nov 1, 2024 | TD Cowen | maintain | Buy | Buy |
| Nov 1, 2024 | Roth MKM | maintain | Buy | Buy |
| Nov 1, 2024 | Piper Sandler | maintain | Neutral | Neutral |
| Nov 1, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Nov 1, 2024 | Baird | maintain | Outperform | Outperform |
| Aug 21, 2024 | Roth MKM | maintain | Buy | Buy |
| Aug 5, 2024 | Stephens & Co. | maintain | Equal Weight | Equal Weight |
| Aug 2, 2024 | Roth MKM | maintain | Buy | Buy |
| Aug 2, 2024 | Baird | maintain | Outperform | Outperform |
| Jul 22, 2024 | Piper Sandler | maintain | Neutral | Neutral |
| Jul 17, 2024 | Oppenheimer | maintain | Outperform | Outperform |